US Stock MarketDetailed Quotes

ORMP Oramed Pharmaceuticals

Watchlist
  • 2.520
  • +0.030+1.20%
Close Jul 12 16:00 ET
  • 2.500
  • -0.020-0.79%
Post 17:55 ET
102.38MMarket Cap9.69P/E (TTM)

Oramed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Oramed Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

-100.00%
EPS(YoY)

0.04

+150.00%
Analyst Rating

Hold

May 20, 2024

Oramed Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 250.000K--
--2022/Q3-- / 687.000K--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 700.000K--
--2023/Q2674.000K / 700.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 250.000K--
--2022/Q3-- / 687.000K--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 700.000K--
--2023/Q2674.000K / 700.000K--

Unlock Free Earnings Estimates

Oramed Pharmaceuticals Earnings Reports

  • Oramed Pharmaceuticals | 10-Q: Quarterly report

    May 9 17:06 ET

  • Oramed Pharmaceuticals | 10-K: Annual report

    Mar 6 17:06 ET

  • Oramed Pharmaceuticals: Q3 2023 Earnings Report

    Nov 9, 2023 17:10 ET

  • Oramed Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 17:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 20, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg